What are the indications, appropriate dosing regimens, and contraindications for diphenhydramine syrup?

Diphenhydramine Syrup: Indications, Dosing, and Contraindications

Diphenhydramine syrup is indicated primarily for allergic reactions including urticaria, allergic rhinitis, and as second-line adjunctive therapy in anaphylaxis (never as monotherapy), with standard dosing of 1-2 mg/kg (maximum 25-50 mg per dose) every 4-6 hours, but should be avoided in children under 6 years for cold/cough symptoms and used cautiously in patients with chronic bronchitis, glaucoma, or prostatic hypertrophy.

Primary Indications

Allergic Conditions

• Acute hypersensitivity reactions including urticaria and allergic rhinitis 1
• Anaphylaxis - but only as second-line adjunctive therapy after epinephrine, never alone 2
• Dystonic reactions 1

Important Caveat on Anaphylaxis

Diphenhydramine is explicitly second-line therapy in anaphylaxis management. Guidelines emphasize that H1-antihistamines should never be administered alone and have a much slower onset than epinephrine 2. The combination of diphenhydramine with ranitidine (an H2-blocker) is superior to diphenhydramine alone 2.

Adjunctive Uses

• Sedation adjunct for endoscopic and minor procedures 3
• Short-term insomnia in adults (over-the-counter use) 4

Dosing Regimens

Oral Dosing (Syrup)

Children:

• Ages 6 to <12 years: 10 mL (25 mg) every 4-6 hours 5
• Ages ≥12 years and adults: 10-20 mL (25-50 mg) every 4-6 hours 5
• Under 6 years: Do not use for cold/cough symptoms 5
• Maximum: 6 doses in 24 hours 5

Weight-based dosing (when indicated):

• 1-2 mg/kg per dose 2, 1, 6
• Maximum single dose: 50 mg 6

Parenteral Dosing (for reference)

Anaphylaxis/Acute Allergic Reactions:

• 1-2 mg/kg or 25-50 mg per dose (IV/IM) 2

Procedural Sedation:

• 25-50 mg IV (adults) 3
• Onset: several minutes; Duration: 4-6 hours 3

Pharmacokinetic Considerations

Age significantly affects diphenhydramine clearance 7:

• Children (mean age 8.9 years): Half-life 5.4 hours, clearance 49.2 mL/min/kg
• Young adults: Half-life 9.2 hours, clearance 23.3 mL/min/kg
• Elderly (mean age 69.4 years): Half-life 13.5 hours, clearance 11.7 mL/min/kg

This explains why children may require more frequent dosing and elderly patients are at higher risk for prolonged sedation and anticholinergic effects.

Contraindications and Precautions

Absolute Contraindications (FDA Label)

• Do not use to make a child sleepy 5
• Do not use with any other product containing diphenhydramine, including topical preparations 5

Relative Contraindications - Ask a Doctor Before Use

• Chronic bronchitis or other breathing problems 5
• Glaucoma 5
• Prostatic hypertrophy with urinary retention 5
• Pregnancy or breastfeeding 5

Age-Specific Restrictions

Children under 6 years: The FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended against OTC cough/cold medications (including diphenhydramine) for children below 6 years due to lack of efficacy and potential toxicity 8. Between 1969-2006, there were 69 fatalities associated with antihistamines in children ≤6 years, with 41 occurring in children <2 years 8.

Drug Interactions and Warnings

• Avoid alcohol - increases sedation 5
• Sedatives and tranquilizers - may increase drowsiness 5
• Opioid narcotics - enhanced hypnotic effect, though diphenhydramine may counteract opioid-induced hypoventilation 3
• Impaired driving/machinery operation - marked drowsiness may occur 5

Adverse Effects Profile

Common Side Effects

• Sedation (most common - 95% in pediatric studies) 9
• Anticholinergic effects: dry mouth, blurred vision, urinary retention 3
• Paradoxical excitability (especially in children) 5

Serious Adverse Effects

• Hypotension (especially with rapid IV administration) 3
• Respiratory depression (when combined with other CNS depressants) 1
• Seizures (in overdose) 10, 11
• Wheezing, epigastric discomfort 3

Toxicity Thresholds

Based on overdose data 10, 11:

• Moderate symptoms: occur above 0.3 g (300 mg)
• Severe symptoms (delirium, seizures, coma): occur above 1.0 g
• Toxic dose requiring ED referral:
  • Children <6 years: ≥7.5 mg/kg 11
  • Patients ≥6 years: ≥7.5 mg/kg or 300 mg (whichever is less) 11

Critical Clinical Pitfalls

1. Never use diphenhydramine as monotherapy for anaphylaxis - epinephrine is first-line 2

2. Avoid in children <6 years for cold/cough symptoms - no proven efficacy and significant toxicity risk 8

3. Do not combine with other diphenhydramine-containing products - risk of unintentional overdose 5

4. Monitor elderly patients closely - prolonged half-life increases risk of falls, confusion, and anticholinergic toxicity 7

5. Recent evidence questions routine ED use - Despite 2020 AAAAI guidelines discouraging first-generation antihistamines in anaphylaxis, 62% of US EDs still routinely administer diphenhydramine for anaphylaxis/urticaria with no change from 2019-2021 12. Second-generation antihistamines (cetirizine, loratadine) have better safety profiles in children 8.